AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases (IMAGE)

InSilico Medicine

AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases

Caption

According to the collaboration agreement, the two parties will combine Insilico Medicine’s validated AI platform and AI-enabled innovative drug discovery and development capabilities with CMS’s experienced R&D team and deep disease-area expertise to jointly advance the co-development of no fewer than two R&D programs.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.